Sue Sun Yom, MD, PhD, on Quality of Life After Deintensified Radiotherapy for Oropharyngeal Cancer

Posted: Monday, September 30, 2019

Sue Sun Yom, MD, PhD, of the University of California, San Francisco, discusses whether recent trial data will have an impact on the use of reduced-dose intensity-modulated radiotherapy with or without cisplatin in treating patients with oropharyngeal cancer.